Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Immunology - A Pathway Through the Maze

29 Apr 2014 - 30 Apr 2014 - Department for Continuing Education, Oxford



Bookmark and Share


Immunology is a rapidly developing subject with wide-ranging implications for the pharmaceutical, healthcare and biotechnology industries.

Common questions include, for example: How does the immune system defend the body against infection? What goes wrong when autoimmunity develops? How can undesirable responses be controlled?

Team leaders, R&D directors, and researchers at the bench all need to understand the latest developments in immunology and their implications for drug discovery and development as well as disease treatment. An understanding of the fundamental features of the immune system is essential not only for those who work in areas directly related to infection and immunity, but also for those working in the development of biopharmaceuticals, vaccines and antibody therapy, who wish to exploit the technological advances that have resulted from our increased insight into how the system functions.

As well as offering a path through the immunology maze, the course will emphasize the R&D opportunities for therapeutic intervention that arise from recent advances in immunology, for example the use of therapeutic antibodies and recombinant molecules as potential drug treatments. After the introductory session, each lecture will begin by covering the basic concepts of a particular area of immunology; these will then be developed in such a way that participants are rapidly brought an understanding of the most recent findings.

Oxford is a leading centre in the creative development and application of the theory and techniques of immunology in collaboration with industry. The presenters are leading scientists in their fields and use these techniques in their day-to-day research. They work in the Nuffield Department of Surgery at the University of Oxford.



Further information
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!